The latest clinical trial of the world’s leading malaria vaccine candidate produced disappointing results on Friday. The infants it was given to had only about a third fewer infections than a control group. Three shots of the vaccine, known as RTS, S or Mosquirix and produced by GlaxoSmithKline, gave babies fewer than 12 weeks old 31 percent protection against detectable malaria and 37 percent … [Read more...]
Malaria Vaccine
QUESTION What is the shot you get to prevent malaria? ANSWER There is currently no shot available to prevent malaria. The most promising vaccine candidate, called RTS,S and being developed by GlaxoSmithKline, is currently undergoing Phase III trials in children in Africa. Preliminary results have indicated it may prevent up to 50% of malaria cases, though this varies by age group and … [Read more...]
Why not create a vaccine for malaria?
QUESTION Why not create a vaccine for malaria? ANSWER There are many teams of scientists working hard to try to produce a malaria vaccine. In fact, only last year, the preliminary results of a vaccine trial were published. The vaccine, called RTS,S, has been produced by GlaxoSmithKline and is in the midst of Phase III trials in Africa. The preliminary results showed approximately a … [Read more...]
Malaria Vaccine Research
QUESTION Is there any research to produce anti malaria vaccine, if not, why? ANSWER There are many teams of scientists working hard to try to produce a malaria vaccine. In fact, only last year, the preliminary results of a vaccine trial were published. The vaccine, called RTS,S, has been produced by GlaxoSmithKline and is in the midst of Phase III trials in Africa. The preliminary … [Read more...]
Malaria Vaccine
QUESTION For how long does this vaccine work? ANSWER There is not yet a commercially available vaccine against malaria. Recently, results were published (in the New England Journal of Medicine - press releases and news reports about the study are available through the main page of www.malaria.com) presenting preliminary findings of the first Phase 3 clinical trial for a vaccine, called … [Read more...]
The “E” word and the “V” word: Two Holy Grails of Malaria Control
The Roll Back Malaria Partnership talks confidently of elimination—many others question if this is possible without new interventions. The recent publication of the first Phase 3 clinical trial for a malaria vaccine shows promise, but is it actually good enough? REVIEW OF: Roll Back Malaria Partnership, “Eliminating Malaria: Learning from the Past, Looking Ahead”, Progress & … [Read more...]
GSK and Johnson & Johnson Announce Malaria Vaccine Collaboration
GlaxoSmithKline Biologicals (GSK Bio) and Crucell NV (Johnson & Johnson) have announced a collaboration to develop a vaccine approach aimed at boosting the efficacy of the world’s most clinically advanced malaria vaccine candidate, RTS,S. The PATH Malaria Vaccine Initiative (MVI) today congratulated the companies on the partnership. "We are excited by the potential of this new endeavor for … [Read more...]